{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_phenelzine",
          "name": "Phenelzine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_selegiline",
          "name": "Selegiline"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_fluoxetine",
          "name": "Fluoxetine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_paroxetine",
          "name": "Paroxetine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_bupropion",
          "name": "Bupropion"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_clomipramine",
          "name": "Clomipramine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sertraline",
          "name": "Sertraline"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_venlafaxine",
          "name": "Venlafaxine"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_thioridazine",
          "name": "Thioridazine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_risperidone",
          "name": "Risperidone"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_tranylcypromine",
          "name": "Tranylcypromine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_citalopram",
          "name": "Citalopram"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot1",
          "type": "Target",
          "label": "MAO Inhibition",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot2",
          "type": "Target",
          "label": "Serotonin Reuptake Inhibition",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp1",
          "type": "Pathway",
          "label": "Hypertensive Crisis Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp2",
          "type": "Pathway",
          "label": "Serotonin Syndrome Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "Crisis Symptoms",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv2",
          "type": "Phenotype",
          "label": "Neurological Adverse Events",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_phenelzine",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知对 MAO 有活性，可能导致禁忌症"
        },
        {
          "source": "drug_selegiline",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能与 MAO 抑制作用产生交互"
        },
        {
          "source": "drug_fluoxetine",
          "target": "n_ot2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "选择性抑制血清素再摄取，可能导致综合症"
        },
        {
          "source": "drug_paroxetine",
          "target": "n_ot2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能加强血清素的不良反应"
        },
        {
          "source": "drug_bupropion",
          "target": "n_ot2",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "虽主要作用于多巴胺，但可能影响血清素"
        },
        {
          "source": "n_ot1",
          "target": "n_rp1",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与高血压危机相关的反应路径"
        },
        {
          "source": "n_ot2",
          "target": "n_rp2",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与血清素综合症相关的反应路径"
        },
        {
          "source": "n_rp1",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "可导致高血压危机相关症状"
        },
        {
          "source": "n_rp2",
          "target": "n_adv2",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "可导致神经系统的副作用"
        },
        {
          "source": "n_adv1",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若发生，则可抵消该药物的治疗益处"
        },
        {
          "source": "n_adv2",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若发生，则可抵消该药物的治疗益处"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "drug_interactions",
          "pro_nodes": [
            "drug_phenelzine",
            "drug_selegiline"
          ],
          "con_nodes": [
            "n_rp1",
            "n_rp2"
          ],
          "note": "药物间相互作用应受重视"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "存在已知的与其他药物相互作用导致的禁忌症",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "不同机制可能相互强化不良反应",
        "confidence": "high"
      }
    ],
    "assumptions_challenged": [
      "药物组合的相互作用是否充分理解",
      "各药物对经典病理机制的影响程度"
    ],
    "falsification_tests": [
      "是否有证据表明药物联合使用不会导致严重不良反应？",
      "是否有临床数据证实长期使用与疗效无显著差异？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 列出药物间相互作用的最新文献",
      "探讨复合治疗对患者安全性的具体影响"
    ]
  }
}